Evidence map›Paper›PMID 38670669›Full record

Trial reportBehavior therapy2024

A Randomized Controlled Pilot Trial of Primary Care Treatment Integrating Motivation and Exposure Treatment (PC-TIME) in Veterans With PTSD and Harmful Alcohol Use.

Kyle Possemato, Nadine R Mastroleo, Christina Balderrama-Durbin, Paul King, Ariella Davis, Brian Borsari, Sheila A M Rauch

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Behavior therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Kyle PossematoVA Center for Integrated Healthcare, Syracuse and Buffalo. Electronic address: Kyle.Possemato@va.gov.
Nadine R MastroleoBinghamton University.
Christina Balderrama-DurbinBinghamton University.
Paul KingVA Center for Integrated Healthcare, Syracuse and Buffalo; and University at Buffalo.
Ariella DavisVA Center for Integrated Healthcare, Syracuse and Buffalo.
Brian BorsariSan Francisco VA Health Care System and University of California, San Francisco.
Sheila A M Rauch|Atlanta VA Healthcare System and Emory University School of Medicine.
SUNY Upstate Medical University · USBinghamton University · USEmory Healthcare · USUniversity of California, San Francisco · US

Funding

An Integrated Brief Alcohol and PTSD Intervention for Veterans in Primary CareR34AA026745 · NIAAA · STATE UNIVERSITY OF NY,BINGHAMTON · PI MASTROLEO, NADINE RACHEL, POSSEMATO, KYLE · 2018 to 2020
$616k
NIAAA NIH HHS R34 AA026745
6 · The paper itself

Abstract

Individuals with posttraumatic stress disorder (PTSD) often engage in harmful alcohol use. These co-occurring conditions are associated with negative health consequences and disability. PTSD and harmful drinking are typically experienced as closely related-thus treatments that target both simultaneously are preferred by patients. Many individuals with PTSD and harmful alcohol use receive primary care services but encounter treatment barriers in engaging in specialty mental health and substance use services. A pilot randomized controlled trial of a brief integrated treatment for PTSD and harmful drinking versus primary care treatment as usual (PC-TAU) took place in three U.S. Department of Veterans Affairs (VA) primary care clinics. The intervention (primary care treatment integrating motivation and exposure [PC-TIME]) combines motivational interviewing to reduce alcohol use and brief prolonged exposure for PTSD delivered over five brief sessions. Participants (N = 63) were veterans with PTSD and harmful drinking. Multilevel growth curve modeling examined changes in drinking (average number of drinks per drinking day and percentage of heavy drinking days) and self-reported PTSD severity at baseline, 8, 14, and 20 weeks. Participants reported high satisfaction with PC-TIME and 70% (n = 23) completed treatment. As hypothesized, a significantly steeper decrease in self-reported PTSD severity and heavy drinking was evident for participants randomized to PC-TIME compared with PC-TAU. Contrary to expectations, no significant posttreatment differences in PTSD diagnoses were observed. PC-TIME participants were less likely to exceed National Institute for Alcoholism and Alcohol Abuse (NIAAA) guidelines for harmful alcohol use posttreatment compared with PC-TAU participants. PC-TIME is a promising brief, primary care-based treatment for individuals with co-occurring PTSD and harmful alcohol use. A full-scale randomized clinical trial is needed to fully test its effectiveness.

Indexed as

AlcoholismMotivational InterviewingPrimary Health CareStress Disorders, Post-TraumaticVeteransAdultFemaleHumansImplosive TherapyMaleMiddle AgedMotivationPilot ProjectsTreatment OutcomeUnited StatesAUDmotivational interviewingprimary careprolonged exposurePTSD

Identifiers

PMID38670669
PMCPMC11056732
OpenAlexW4386583140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.